Harvey Capital Management Inc Gilead Sciences, Inc. Transaction History

Harvey Capital Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1.4 Million - $1.6 Million	-24,765 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $111,780 - $140,544	-1,800 Reduced 6.78%	24,765 $1.56 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $2.59 Million - $3.01 Million	-35,825 Reduced 57.42%	26,565 $2.04 Million
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $1.59 Million - $2.04 Million	-25,400 Reduced 28.93%	62,390 $4.66 Million
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $87,808 - $96,586	-1,425 Reduced 1.6%	87,790 $5.7 Million
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $37,506 - $41,400	-600 Reduced 0.67%	89,215 $5.65 Million
Q2 2019 Jul 23, 2019	SELL	$61.87 - $69.38 $52,589 - $58,972	-850 Reduced 0.94%	89,815 $6.07 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $105,050 - $117,684	-1,680 Reduced 1.82%	90,665 $5.89 Million
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $166,485 - $217,250	-2,750 Reduced 2.89%	92,345 $5.78 Million
Q3 2018 Oct 24, 2018	BUY	$71.28 - $78.92 $42,768 - $47,352	600 Added 0.63%	95,095 $7.34 Million
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $85,966 - $100,276	-1,325 Reduced 1.38%	94,495 $6.69 Million
Q1 2018 Apr 27, 2018	SELL	$72.84 - $88.8 $20,395 - $24,864	-280 Reduced 0.29%	95,820 $7.22 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $505,876 - $593,827	-7,110 Reduced 6.89%	96,100 $6.88 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $7.44 Million - $8.82 Million	103,210	103,210 $8.36 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Harvey Capital Management Inc with notifications on news.